_id
69148a70ccc777a4e85d98fe
Ticker
PBIGF
Name
Paradigm Biopharmaceuticals Limited
Exchange
PINK
Address
500 Collins Street, Melbourne, VIC, Australia, 3000
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.paradigmbiopharma.com
Description
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Last Close
0.2331
Volume
-
Current Price
0.237
Change
0
Last Updated
2026-01-06T08:54:27.844Z
Image
data:image/webp;base64,UklGRrwDAABXRUJQVlA4ILADAADQEACdASpAAEAAPslQm0unpKIhtfdLMPAZCWwAvRNwvfD+ekTbh88xptO8sf4qgiNDqhxyW5oVit13wmj6T2d3WpfP3/lhMesVpb4gPJ9FzCM0T2iA12fJG2MkAmo+DrryCFyL+4ikJFqtNIt1Ya7HvOcvKfjBPCCBAUB5SLLeGrHdWT5A3Puvo5s/GqqiAAD+/sKg5n7tLSbm0aScsrGQKpVrrX9lqc+JR1m/puIQNxk8Ow77z4h4m6fvN4NfQHBIixs/UgmbpCBY3jTIwPmWPdyt9cNfCyBbsakSMjYmcJQ6vvXRyarhpoNZtqQ1F/d5KpKzq84hQa/h3JaT1FTUVu7HMWF7NO17FUV5IhmKoUJ604bQ+qUDYq4ZiqXj7Jlp2Vlnr+mrsAWjTTWP/hAD41DAV5NAS9YI5PyqJ9K3daEzT+1DBpHKvD7zMWN1VuQvqPm4r/AgKOYAQp0tsrA4jRArDGuB18hdRHgHaTKOO6jqDtvk+qp2kYs8PwpbiqXSCU2ygXcIe9OTfgfujDFi/4gMDYlkncYqlrod/TMUZNdPoYMmS11tMRBqQPWqfvBZDTn3vgEUdfCtfGpeKhQzXU/jeQ3uDRnY0O9ar38uomgT6JgA+UHdAI5ePYTQ6adcWgR2cmboI/NuwriLW7b41cio9QBvUNlkzH0F8KfaG8DXjiYOsFL1sVIat7zgjH9AZSLBwZMSdWwg0dZ7tHhMZ/w2J5g5RAnceHRLctkT6i1N7642Bnu/KTshG2N8K1ShNr4Wsumk9Nvra4obECwVZCKQPEf4abRBMmzFgF8aw8uZAJSskX/yA0Xx50mqjpTXH9GtLoNswHmHBLawLQYtDJBeOeQw4rhEe7bFpgb329AJaxnUxIzJ6f6ONYaBVUm+bN2D5DHvATZX7EaNJBNCGGfzK0nW/mGpQ7xPTZNdXndGlGdEWblPdU4UN1JBqf4l48KkD1gUUvj3vg54mbjbxlCMHgU1gToHt5zl2e8Gj/JbjPqcxv9cN3sI11Maiqvi/eXGyYHNDzDlSIsAyqfn4mlQfAf9JEaFtngCUh5wzhMYh5DPSdx2p1Q8qgBsEzQiBHHvPAzhcPKlCxh68CyT/FvRXJLkQK6zTUQ2kysGsGlASzz0yVelBptmEdUQQqI6w7TVk8RtvuPQxVFCcbGjcJ7eeqjbDAhX3kJQbWr+f/qs2AljqhPKNlqdThP2SA3ESMufjBQ3lhI1v/Ub8TCAGeGxHh+yPVHexx/LMAAAAA==
Ipo Date
-
Market Cap
99887816
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
35420
Cost Of Revenue
81825
Gross Profit
-46405
Operating Expenses
16758158
Operating Income
-16804563
Interest Expense
2843
Pretax Income
-19048803
Net Income
-12846693
Eps
-0.0329885520569185
Dividends Per Share
-
Shares Outstanding
428519176
Income Tax Expense
-6202110
EBITDA
-18966011
Operating Margin
-47443.71259175607
Total Other Income Expense Net
-2244240
Cash
16818129
Short Term Investments
-
Receivables
6373827
Inventories
-
Total Current Assets
24126969
Property Plant Equipment
29828
Total Assets
24571532
Payables
2734861
Short Term Debt
5484
Long Term Debt
-
Total Liabilities
3387495
Equity
21184037
Bs_currency_symbol
-
Depreciation
79949
Change In Working Capital
2519274
Cash From Operations
-7773553
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
-124209
Net Change In Cash
-7960212
Cf_currency_symbol
-
PE
-
PB
4.3568008803515585
ROE
-60.64327115742859
ROA
-52.28283283272691
FCF
-7773556
Fcf Percent
-219.46798418972332
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
35420
Quarters > 0 > income Statement > cost Of Revenue
81825
Quarters > 0 > income Statement > gross Profit
-46405
Quarters > 0 > income Statement > operating Expenses
16758158
Quarters > 0 > income Statement > operating Income
-16804563
Quarters > 0 > income Statement > interest Expense
2843
Quarters > 0 > income Statement > pretax Income
-19048803
Quarters > 0 > income Statement > net Income
-12846693
Quarters > 0 > income Statement > eps
-0.0329885520569185
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
389428823
Quarters > 0 > income Statement > income Tax Expense
-6202110
Quarters > 0 > income Statement > EBITDA
-18966011
Quarters > 0 > income Statement > operating Margin
-47443.71259175607
Quarters > 0 > income Statement > total Other Income Expense Net
-2244240
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
16818129
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
6373827
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24126969
Quarters > 0 > balance Sheet > property Plant Equipment
29828
Quarters > 0 > balance Sheet > total Assets
24571532
Quarters > 0 > balance Sheet > payables
2734861
Quarters > 0 > balance Sheet > short Term Debt
5484
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3387495
Quarters > 0 > balance Sheet > equity
21184037
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-12846693
Quarters > 0 > cash Flow > depreciation
79949
Quarters > 0 > cash Flow > change In Working Capital
2519274
Quarters > 0 > cash Flow > cash From Operations
-7773553
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-124209
Quarters > 0 > cash Flow > net Change In Cash
-7960212
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0329885520569185
Quarters > 0 > ratios > PB
4.3568008803515585
Quarters > 0 > ratios > ROE
-60.64327115742859
Quarters > 0 > ratios > ROA
-52.28283283272691
Quarters > 0 > ratios > FCF
-7773556
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-219.46798418972332
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
16700
Quarters > 1 > income Statement > cost Of Revenue
18715
Quarters > 1 > income Statement > gross Profit
-2015
Quarters > 1 > income Statement > operating Expenses
6345645
Quarters > 1 > income Statement > operating Income
-6347660
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6255036
Quarters > 1 > income Statement > net Income
-5924052
Quarters > 1 > income Statement > eps
-0.016732428194681494
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
354046163
Quarters > 1 > income Statement > income Tax Expense
-330984
Quarters > 1 > income Statement > EBITDA
-6276188
Quarters > 1 > income Statement > operating Margin
-38009.940119760475
Quarters > 1 > income Statement > total Other Income Expense Net
92624
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
24778341
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
32291038
Quarters > 1 > balance Sheet > property Plant Equipment
118185
Quarters > 1 > balance Sheet > total Assets
35356811
Quarters > 1 > balance Sheet > payables
580837
Quarters > 1 > balance Sheet > short Term Debt
81403
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1301633
Quarters > 1 > balance Sheet > equity
34055178
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-5924052
Quarters > 1 > cash Flow > depreciation
71472
Quarters > 1 > cash Flow > change In Working Capital
-127516
Quarters > 1 > cash Flow > cash From Operations
-8219662
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
46200
Quarters > 1 > cash Flow > cash From Financing
15117677
Quarters > 1 > cash Flow > net Change In Cash
24778341
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.016732428194681494
Quarters > 1 > ratios > PB
2.4639113802605874
Quarters > 1 > ratios > ROE
-17.395451581548038
Quarters > 1 > ratios > ROA
-16.755051806001394
Quarters > 1 > ratios > FCF
-8219662
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-492.19532934131735
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
8350
Quarters > 2 > income Statement > cost Of Revenue
9358
Quarters > 2 > income Statement > gross Profit
-1008
Quarters > 2 > income Statement > operating Expenses
3172823
Quarters > 2 > income Statement > operating Income
-3173831
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2962026
Quarters > 2 > income Statement > net Income
-2962026
Quarters > 2 > income Statement > eps
-0.008366214097340747
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
354046163
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3138094
Quarters > 2 > income Statement > operating Margin
-38009.95209580838
Quarters > 2 > income Statement > total Other Income Expense Net
211805
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
35736
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.008366214097340747
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
65800
Quarters > 3 > income Statement > cost Of Revenue
-64409
Quarters > 3 > income Statement > gross Profit
130209
Quarters > 3 > income Statement > operating Expenses
14957000
Quarters > 3 > income Statement > operating Income
-14966000
Quarters > 3 > income Statement > interest Expense
7891
Quarters > 3 > income Statement > pretax Income
-14681000
Quarters > 3 > income Statement > net Income
-9695000
Quarters > 3 > income Statement > eps
-0.033806755771906394
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
286777000
Quarters > 3 > income Statement > income Tax Expense
-4986000
Quarters > 3 > income Statement > EBITDA
-14892000
Quarters > 3 > income Statement > operating Margin
-22744.68085106383
Quarters > 3 > income Statement > total Other Income Expense Net
284735
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
17820827
Quarters > 3 > balance Sheet > short Term Investments
46200
Quarters > 3 > balance Sheet > receivables
5082505
Quarters > 3 > balance Sheet > inventories
-5082505
Quarters > 3 > balance Sheet > total Current Assets
24253194
Quarters > 3 > balance Sheet > property Plant Equipment
189656
Quarters > 3 > balance Sheet > total Assets
27390438
Quarters > 3 > balance Sheet > payables
2821157
Quarters > 3 > balance Sheet > short Term Debt
121842
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3584341
Quarters > 3 > balance Sheet > equity
23806097
Quarters > 3 > balance Sheet > currency_symbol
AUD
Quarters > 3 > cash Flow > net Income
-9694801
Quarters > 3 > cash Flow > depreciation
73339
Quarters > 3 > cash Flow > change In Working Capital
1452104
Quarters > 3 > cash Flow > cash From Operations
-14921759
Quarters > 3 > cash Flow > capital Expenditures
14921759
Quarters > 3 > cash Flow > cash From Investing
-46200
Quarters > 3 > cash Flow > cash From Financing
-125545
Quarters > 3 > cash Flow > net Change In Cash
-15730143
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.033806755771906394
Quarters > 3 > ratios > PB
2.854989165170586
Quarters > 3 > ratios > ROE
-40.72486136639702
Quarters > 3 > ratios > ROA
-35.39556395556727
Quarters > 3 > ratios > FCF
-29843518
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-453.548905775076
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
52120
Annuals > 0 > income Statement > cost Of Revenue
72012
Annuals > 0 > income Statement > gross Profit
-19892
Annuals > 0 > income Statement > operating Expenses
22866313
Annuals > 0 > income Statement > operating Income
-22886205
Annuals > 0 > income Statement > interest Expense
7082
Annuals > 0 > income Statement > pretax Income
-25303839
Annuals > 0 > income Statement > net Income
-18770745
Annuals > 0 > income Statement > eps
-0.05968419050864823
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
314501124
Annuals > 0 > income Statement > income Tax Expense
-6533094
Annuals > 0 > income Statement > EBITDA
-25245337
Annuals > 0 > income Statement > operating Margin
-43910.6005372218
Annuals > 0 > income Statement > total Other Income Expense Net
-2417634
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
16818129
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
6373827
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
24126969
Annuals > 0 > balance Sheet > property Plant Equipment
29828
Annuals > 0 > balance Sheet > total Assets
24571532
Annuals > 0 > balance Sheet > payables
2734861
Annuals > 0 > balance Sheet > short Term Debt
5484
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3387495
Annuals > 0 > balance Sheet > equity
21184037
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-18770745
Annuals > 0 > cash Flow > depreciation
51421
Annuals > 0 > cash Flow > change In Working Capital
97801
Annuals > 0 > cash Flow > cash From Operations
-15993215
Annuals > 0 > cash Flow > capital Expenditures
5
Annuals > 0 > cash Flow > cash From Investing
46200
Annuals > 0 > cash Flow > cash From Financing
14993468
Annuals > 0 > cash Flow > net Change In Cash
-1002698
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.05968419050864823
Annuals > 0 > ratios > PB
3.460634628064519
Annuals > 0 > ratios > ROE
-88.60796929310499
Annuals > 0 > ratios > ROA
-76.39224530240931
Annuals > 0 > ratios > FCF
-15993220
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-306.8537989255564
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
65800
Annuals > 1 > income Statement > cost Of Revenue
8988
Annuals > 1 > income Statement > gross Profit
56812
Annuals > 1 > income Statement > operating Expenses
65103000
Annuals > 1 > income Statement > operating Income
-65193000
Annuals > 1 > income Statement > interest Expense
14370
Annuals > 1 > income Statement > pretax Income
-58653000
Annuals > 1 > income Statement > net Income
-58653000
Annuals > 1 > income Statement > eps
-0.19998704327545996
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
293284000
Annuals > 1 > income Statement > income Tax Expense
-6047117
Annuals > 1 > income Statement > EBITDA
-64539000
Annuals > 1 > income Statement > operating Margin
-99077.5075987842
Annuals > 1 > income Statement > total Other Income Expense Net
6539930
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
17820827
Annuals > 1 > balance Sheet > short Term Investments
46200
Annuals > 1 > balance Sheet > receivables
5082505
Annuals > 1 > balance Sheet > inventories
-5082505
Annuals > 1 > balance Sheet > total Current Assets
24253194
Annuals > 1 > balance Sheet > property Plant Equipment
189656
Annuals > 1 > balance Sheet > total Assets
27390438
Annuals > 1 > balance Sheet > payables
2821157
Annuals > 1 > balance Sheet > short Term Debt
121842
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3584341
Annuals > 1 > balance Sheet > equity
23806097
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-58653188
Annuals > 1 > cash Flow > depreciation
146736
Annuals > 1 > cash Flow > change In Working Capital
-8684985
Annuals > 1 > cash Flow > cash From Operations
-65944671
Annuals > 1 > cash Flow > capital Expenditures
65944671
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
28176953
Annuals > 1 > cash Flow > net Change In Cash
-38512258
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.19998704327545996
Annuals > 1 > ratios > PB
2.8717223323084
Annuals > 1 > ratios > ROE
-246.37806020869363
Annuals > 1 > ratios > ROA
-214.13677284021526
Annuals > 1 > ratios > FCF
-131889342
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2004.3972948328267
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
46760
Annuals > 2 > income Statement > cost Of Revenue
18827
Annuals > 2 > income Statement > gross Profit
27933
Annuals > 2 > income Statement > operating Expenses
60066440
Annuals > 2 > income Statement > operating Income
-51893597
Annuals > 2 > income Statement > interest Expense
16416
Annuals > 2 > income Statement > pretax Income
-51910013
Annuals > 2 > income Statement > net Income
-51910013
Annuals > 2 > income Statement > eps
-0.17919901752980896
Annuals > 2 > income Statement > dividends Per Share
416341
Annuals > 2 > income Statement > shares Outstanding
289678000
Annuals > 2 > income Statement > income Tax Expense
-7042194
Annuals > 2 > income Statement > EBITDA
-51893597
Annuals > 2 > income Statement > operating Margin
-110978.60778443114
Annuals > 2 > income Statement > total Other Income Expense Net
6742333
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
56333085
Annuals > 2 > balance Sheet > short Term Investments
46200
Annuals > 2 > balance Sheet > receivables
6807301
Annuals > 2 > balance Sheet > inventories
46200
Annuals > 2 > balance Sheet > total Current Assets
63785664
Annuals > 2 > balance Sheet > property Plant Equipment
336392
Annuals > 2 > balance Sheet > total Assets
67069644
Annuals > 2 > balance Sheet > payables
12161182
Annuals > 2 > balance Sheet > short Term Debt
104971
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
13391873
Annuals > 2 > balance Sheet > equity
53677771
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-51910013
Annuals > 2 > cash Flow > depreciation
153656
Annuals > 2 > cash Flow > change In Working Capital
5333753
Annuals > 2 > cash Flow > cash From Operations
-45186279
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
62534622
Annuals > 2 > cash Flow > net Change In Cash
16658672
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.17919901752980896
Annuals > 2 > ratios > PB
1.2579498094285622
Annuals > 2 > ratios > ROE
-96.70672241587677
Annuals > 2 > ratios > ROA
-77.3971798627707
Annuals > 2 > ratios > FCF
-45186279
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-966.3447177074422
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
79224
Annuals > 3 > income Statement > cost Of Revenue
143751
Annuals > 3 > income Statement > gross Profit
-64527
Annuals > 3 > income Statement > operating Expenses
47926000
Annuals > 3 > income Statement > operating Income
-47929557
Annuals > 3 > income Statement > interest Expense
28633
Annuals > 3 > income Statement > pretax Income
-47013000
Annuals > 3 > income Statement > net Income
-39250000
Annuals > 3 > income Statement > eps
-0.16231148090100447
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
241819000
Annuals > 3 > income Statement > income Tax Expense
-7763000
Annuals > 3 > income Statement > EBITDA
-46817000
Annuals > 3 > income Statement > operating Margin
-60498.78445925477
Annuals > 3 > income Statement > total Other Income Expense Net
916557
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
39674413
Annuals > 3 > balance Sheet > short Term Investments
46200
Annuals > 3 > balance Sheet > receivables
6718798
Annuals > 3 > balance Sheet > inventories
46200
Annuals > 3 > balance Sheet > total Current Assets
47170126
Annuals > 3 > balance Sheet > property Plant Equipment
571155
Annuals > 3 > balance Sheet > total Assets
50688869
Annuals > 3 > balance Sheet > payables
7088279
Annuals > 3 > balance Sheet > short Term Debt
147758
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8376258
Annuals > 3 > balance Sheet > equity
42312611
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-39249584
Annuals > 3 > cash Flow > depreciation
193250
Annuals > 3 > cash Flow > change In Working Capital
4439410
Annuals > 3 > cash Flow > cash From Operations
-32205266
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
70116
Annuals > 3 > cash Flow > net Change In Cash
-31360570
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.16231148090100447
Annuals > 3 > ratios > PB
1.33217987658573
Annuals > 3 > ratios > ROE
-92.76194276926091
Annuals > 3 > ratios > ROA
-77.43317374076743
Annuals > 3 > ratios > FCF
-32205266
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-406.50896193072805
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.0329885520569185
Valuation > metrics > PB
4.3568008803515585
Valuation > final Score
36.43199119648442
Valuation > verdict
45.2% Overvalued
Profitability > metrics > ROE
-60.64327115742859
Profitability > metrics > ROA
-53.246195160278944
Profitability > metrics > Net Margin
-362.6960191981931
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15990790612761865
Risk > metrics > Interest Coverage
-5910.8557861414
Risk > final Score
-23583
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.804354561195762
Liquidity > metrics > Quick Ratio
8.804354561195762
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
50
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
35
Prev Profitabilities > 2
0
Prev Risks > 0
-1140
Prev Risks > 1
-42
Prev Risks > 2
-7526
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T22:22:24.341Z
Earnings History > 0 > period
2021-03-31
Earnings History > 0 > report Date
2021-06-30
Earnings History > 0 > date
2021-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
AUD
Earnings History > 0 > eps Actual
-0.028
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.028
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2020-12-31
Earnings History > 1 > report Date
2021-02-22
Earnings History > 1 > date
2020-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
AUD
Earnings History > 1 > eps Actual
-0.0283
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0283
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-09-30
Earnings History > 2 > report Date
2020-12-31
Earnings History > 2 > date
2020-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
AUD
Earnings History > 2 > eps Actual
-0.0351
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0351
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-08-27
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
AUD
Earnings History > 3 > eps Actual
-0.0326
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0326
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-03-31
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
AUD
Earnings History > 4 > eps Actual
-0.012
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.012
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2019-12-31
Earnings History > 5 > report Date
2020-02-13
Earnings History > 5 > date
2019-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
AUD
Earnings History > 5 > eps Actual
-0.0107
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0107
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-09-30
Earnings History > 6 > report Date
2019-12-31
Earnings History > 6 > date
2019-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
AUD
Earnings History > 6 > eps Actual
-0.0093
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0093
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-06-30
Earnings History > 7 > report Date
2019-08-29
Earnings History > 7 > date
2019-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
AUD
Earnings History > 7 > eps Actual
-0.0089
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0089
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-03-31
Earnings History > 8 > report Date
2019-06-30
Earnings History > 8 > date
2019-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
AUD
Earnings History > 8 > eps Actual
-0.0262
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0262
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2018-12-31
Earnings History > 9 > report Date
2019-02-20
Earnings History > 9 > date
2018-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
AUD
Earnings History > 9 > eps Actual
-0.0265
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0265
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-09-30
Earnings History > 10 > report Date
2018-12-31
Earnings History > 10 > date
2018-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
AUD
Earnings History > 10 > eps Actual
-0.012
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.012
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-06-30
Earnings History > 11 > report Date
2018-08-23
Earnings History > 11 > date
2018-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
AUD
Earnings History > 11 > eps Actual
-0.0123
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0123
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-06-30
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
AUD
Earnings History > 12 > eps Actual
-0.0091
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0091
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-31
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
AUD
Earnings History > 13 > eps Actual
-0.0095
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0095
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-12-31
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
AUD
Earnings History > 14 > eps Actual
-0.0115
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0115
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-06-30
Earnings History > 15 > report Date
2017-09-30
Earnings History > 15 > date
2017-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
AUD
Earnings History > 15 > eps Actual
-0.0116
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0116
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-03-31
Earnings History > 16 > report Date
2017-06-30
Earnings History > 16 > date
2017-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
AUD
Earnings History > 16 > eps Actual
-0.0055
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0055
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-12-31
Earnings History > 17 > report Date
2017-03-31
Earnings History > 17 > date
2016-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
AUD
Earnings History > 17 > eps Actual
-0.0055
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0055
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-09-30
Earnings History > 18 > report Date
2016-12-31
Earnings History > 18 > date
2016-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
AUD
Earnings History > 18 > eps Actual
-0.011
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.011
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-06-30
Earnings History > 19 > report Date
2016-09-30
Earnings History > 19 > date
2016-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
AUD
Earnings History > 19 > eps Actual
-0.0117
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0117
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-03-31
Earnings History > 20 > report Date
2016-06-30
Earnings History > 20 > date
2016-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
AUD
Earnings History > 20 > eps Actual
-0.0065
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0065
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2015-12-31
Earnings History > 21 > report Date
2016-03-31
Earnings History > 21 > date
2015-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
AUD
Earnings History > 21 > eps Actual
-0.0067
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0067
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-09-30
Earnings History > 22 > report Date
2015-12-31
Earnings History > 22 > date
2015-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
AUD
Earnings History > 22 > eps Actual
-0.0067
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0067
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-06-30
Earnings History > 23 > report Date
2015-09-30
Earnings History > 23 > date
2015-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
AUD
Earnings History > 23 > eps Actual
-0.0065
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0065
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-03-31
Earnings History > 24 > report Date
2015-06-30
Earnings History > 24 > date
2015-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
AUD
Earnings History > 24 > eps Actual
-0.0151
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0151
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2014-09-30
Earnings History > 25 > report Date
2014-12-31
Earnings History > 25 > date
2014-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
AUD
Earnings History > 25 > eps Actual
-0.015
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.015
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-06-30
Earnings History > 26 > report Date
2014-09-30
Earnings History > 26 > date
2014-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
AUD
Earnings History > 26 > eps Actual
-0.0161
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0161
Earnings History > 26 > surprise Percent
-
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AParadigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook Yahoo Finance
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Paradigm Biopharmaceuticals Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.028
EPS Estimate
0
EPS Difference
-0.028
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.